BNET Industries

Market Cap:$147.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
A Dividend-Stock Holiday Shopping List
-
Pfizer whistleblower wins 2009 honor for business ethics: Complaint led to largest criminal fine in...
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Adimab Signs Deal with Pfizer
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
News & Analysis
Filter by
long-term care and pfizer inc. - All News and Analysis
Verispan: Pfizer Earns Top Honors for Medicare Part D Efforts in Long-Term Care
YARDLEY, Pa. -- Pfizer received the largest number of mentions for best satisfying the needs of long-term care LTC pharmacy providers/consultants with Medicare Part D in Verispan's fall 2005 Nursing Home Pharmacy Provider/Consultant Promotional Audit.
Verispan Audit Ranks Top 10 Pharma Companies in Long-Term Care; Pfizer No. 1
YARDLEY, Pa. -- Pfizer has been selected as the best overall pharmaceutical company by long-term care LTC pharmacists participating in Verispan's spring 2004 Nursing Home Pharmacy Provider/Consultant Promotional Audit.
Johnson &Johnson Wins Plum Honors in Long-Term Care; Pfizer, Merck Score
Business Editors/Health &Medical Writers
Pfizer is first in long-term care
* Long-term care pharmacy executives named Pfizer the pharmaceutical company that best meets their needs in all four categories of business operation assessed by Scott-Levin in its spring 1999 nursing home promotional audit.
Pfizer Sweeps Long-Term Care Audit's Top Honors
NEWTOWN, Pa.--BW HealthWire--August 2, 1999--
- 1
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
